Medical News

RSS

After rejection of increases, Conn. premiums set to decrease

Anthem Blue Cross and Blue Shield's individual-market customers will, on average, see a slight decrease in their premiums next year under new rates approved by the Connecticut Insurance Department. Anthem, the state's largest insurer, initially requested approval to raise rates by an average of 12.5 percent. But the insurance department rejected the proposal and asked the company to resubmit its plan using different calculations. The result: An average premium decrease of 0.1 percent for Anthem customers (Becker, 8/15).

19 Aug 2014

FGF proteins play broad roles in wound healing

Mice missing two important proteins of the vascular system develop normally and appear healthy in adulthood, as long as they don't become injured. If they do, their wounds don't heal properly, a new study shows.

19 Aug 2014

Innate lymphoid cells induce specific T and B cell responses during inflammation

In case of an inflammation the body releases substances that increase the immune defense. During chronic inflammation, this immune response gets out of control and can induce organ damage.

19 Aug 2014

AbbVie CF Scholarship program presents annual academic awards to 40 student scholars

AbbVie today announced the 40 outstanding students with cystic fibrosis (CF) who will each receive $2,500 to pursue their undergraduate or graduate school education during the 2014-2015 school year through the AbbVie CF Scholarship program.

19 Aug 2014

MGH-developed microfluidic device may help study key steps involved in development of tumor metastasis

A microfluidic device developed at Massachusetts General Hospital may help study key steps in the process by which cancer cells break off from a primary tumor to invade other tissues and form metastases.

19 Aug 2014

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

UC Santa Cruz cancer researcher Seth Rubin has received a $350,000 grant to fund his work toward the development of a new class of drugs for treating breast cancer. The grant is a Breast Cancer Research Program Breakthrough Award from the congressionally directed medical research programs of the U.S. Department of Defense.

19 Aug 2014

Feds to withhold some doctor payment data after inconsistencies

The Centers For Medicare & Medicaid Services said Friday that, because of data inconsistencies, a third of the records in a database showing drug and device-maker contributions to doctors will be withheld next month when the website goes live.

19 Aug 2014

Queen's University scientists make breakthrough in fight against hospital superbugs

Scientists at Queen's University Belfast have made a breakthrough in the fight against the most resistant hospital superbugs.

19 Aug 2014

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Decision Resources has expanded its disease-level coverage of the Treatment Algorithms Insight Series, which examines U.S. physicians' prescribing behavior, to provide a quantitative analysis of an agent's penetration into each line of therapy.

19 Aug 2014

Globavir plans to seek approval, launch novel drug for treatment of Ebola infection

Globavir Biosciences, Inc., a biotechnology company developing therapeutics to treat infectious diseases, has announced intentions to develop its lead drug candidate, GBV006, for the treatment of the current Ebola Virus outbreak in West Africa. Globavir will seek approval for the use of GBV006, a combination of Food and Drug Administration approved drugs, through an established compassionate use regulatory pathway.

19 Aug 2014

Combating Medicare fraud proves to be a difficult proposition

The New York Times reports that, despite stepped-up enforcement and investments in anti-fraud efforts, the administration's push has so far not made much progress. Meanwhile, The Washington Post examines a classic Medicare scam.

19 Aug 2014

Lilly and Boehringer Ingelheim's Basaglar (insulin glargine injection) gets FDA's tentative approval

The U.S. Food and Drug Administration today granted tentative approval for Basaglar (insulin glargine injection), which is indicated to improve glycemic control in adults with type 2 diabetes and in combination with mealtime insulin in adults and pediatric patients with type 1 diabetes.

19 Aug 2014

$Study on patients with type 2 diabetes examines fracture risk with antihypertensive treatment$

Study on patients with type 2 diabetes examines fracture risk with antihypertensive treatment

It's time to question the common belief that patients receiving intensive blood pressure treatment are prone to falling and breaking bones. A comprehensive study in people ages 40 to 79 with diabetes, led by Karen Margolis, MD, of HealthPartners Institute for Education and Research in the US, found no evidence supporting this belief.

19 Aug 2014

Medical News

After rejection of increases, Conn. premiums set to decrease

FGF proteins play broad roles in wound healing

Innate lymphoid cells induce specific T and B cell responses during inflammation

AbbVie CF Scholarship program presents annual academic awards to 40 student scholars

MGH-developed microfluidic device may help study key steps involved in development of tumor metastasis

UC Santa Cruz cancer researcher receives $350,000 to develop novel drugs for breast cancer

Feds to withhold some doctor payment data after inconsistencies

Queen's University scientists make breakthrough in fight against hospital superbugs

Decision Resources expands disease-level coverage of Treatment Algorithms Insight Series

Globavir plans to seek approval, launch novel drug for treatment of Ebola infection

Combating Medicare fraud proves to be a difficult proposition

Lilly and Boehringer Ingelheim's Basaglar (insulin glargine injection) gets FDA's tentative approval

Study on patients with type 2 diabetes examines fracture risk with antihypertensive treatment

New cholesterol guidelines can significantly help reduce cardiovascular events

Lymphocyte count predicts papillary RCC patient survival

Physical activity fails to show link with chronic musculoskeletal pain

BRCA2 mutations herald poor prognosis in screen-detected prostate cancer

Study reveals treatment trends for prostate cancer in Japan

Chronic musculoskeletal pain influenced by genetics

Aging Japanese population driving high CAP burden

Membrane proteins in focus: Turning high-risk targets into routine workflows

How metabolic phenotyping can detect viral infections in minutes

Directed enzyme evolution and the Nobel Prize: Making enzymes evolve in the lab

Latest News